Mirae Asset Global Investments
MYGN icon

Mirae Asset Global Investments’s Myriad Genetics MYGN Stock Holding History

Mirae Asset Global Investments’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-3,285
Closed -$86.9K – 1639
2024
Q3 		$86.9K Buy
3,285
+583
+22% +$15.8K ﹤0.01% 1212
2024
Q2 		$65.7K Sell
2,702
-332,015
-99% -$7.28M ﹤0.01% 1194
2024
Q1 		$7.62M Buy
334,717
+149,234
+80% +$3.21M 0.02% 749
2023
Q4 		$3.55M Sell
185,483
-228,288
-55% -$3.95M 0.01% 1021
2023
Q3 		$6.64M Buy
413,771
+32,823
+9% +$625K 0.01% 775
2023
Q2 		$8.83M Buy
380,948
+45,462
+14% +$992K 0.02% 705
2023
Q1 		$7.79M Buy
335,486
+10,064
+3% +$204K 0.02% 733
2022
Q4 		$4.72M Sell
325,422
-74,151
-19% -$1.38M 0.01% 844
2022
Q3 		$7.62M Buy
399,573
+52,099
+15% +$1.2M 0.02% 672
2022
Q2 		$6.31M Buy
347,474
+107,368
+45% +$2.23M 0.02% 761
2022
Q1 		$6.05M Sell
240,106
-44,553
-16% -$1.14M 0.01% 814
2021
Q4 		$7.86M Buy
284,659
+61,532
+28% +$1.78M 0.02% 752
2021
Q3 		$7.21M Buy
223,127
+43,986
+25% +$1.46M 0.02% 743
2021
Q2 		$5.48M Buy
179,141
+8,998
+5% +$260K 0.02% 796
2021
Q1 		$5.18M Buy
170,143
+72,491
+74% +$2.06M 0.02% 726
2020
Q4 		$1.93M Buy
97,652
+22,240
+29% +$359K 0.01% 942
2020
Q3 		$984K Buy
75,412
+23,544
+45% +$298K ﹤0.01% 974
2020
Q2 		$589K Buy
+51,868
New +$737K ﹤0.01% 1091

Other funds holding MYGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return

Mirae Asset Global Investments's MYGN Position: Q4 2024 in Review

Mirae Asset Global Investments sold out of Myriad Genetics (MYGN) in Q4 2024, closing a stake of 3,285 shares — an estimated $86.9K sold.

Mirae Asset Global Investments first reported a position in MYGN in Q2 2020 and held it in 18 quarters. The position peaked at $8.83M in Q2 2023. 221 funds tracked by Wall St. Rank hold MYGN as of Q4 2024.

  • Mirae Asset Global Investments reported no remaining Myriad Genetics position as of Q4 2024 after selling out during the quarter.
  • Mirae Asset Global Investments sold 3,285 Myriad Genetics shares in Q4 2024, an estimated $86.9K.
  • Mirae Asset Global Investments first reported a position in Myriad Genetics in Q2 2020 and held it in 18 quarters.
  • Mirae Asset Global Investments's Myriad Genetics position peaked at $8.83M in Q2 2023.
  • 221 funds tracked by Wall St. Rank held Myriad Genetics as of Q4 2024.

Based on Mirae Asset Global Investments's 13F filing for Q4 2024, filed 27 Jan 2025.